Publications en collaboration avec des chercheurs de Instituto de Neurociencias de Castilla y León (1)

2020

  1. Opipramol inhibits lipolysis in human adipocytes without altering glucose uptake and differently from antipsychotic and antidepressant drugs with adverse effects on body weight control

    Pharmaceuticals, Vol. 13, Núm. 3